Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2023-07-17 Purchase | 2023-07-19 4:17 pm | Theseus Pharmaceuticals Inc. | THRX | GORDON CARL L Director 10% Owner | 479,932 | $3.05 | $1,463,793 | 650,600 (Indirect) | View |
| 2023-07-17 Purchase | 2023-07-19 4:15 pm | Theseus Pharmaceuticals Inc. | THRX | ORBIMED ADVISORS LLC OrbiMed Genesis GP LLC OrbiMed Capital GP VII LLC Director 10% Owner | 479,932 | $3.05 | $1,463,793 | 650,600 (Indirect) | View |
| 2023-07-17 Purchase | 2023-07-19 2:54 pm | Theseus Pharmaceuticals Inc. | THRX | Foresite Capital Management V LLC Foresite Capital Fund V L.P. Foresite Capital Opportunity Fund V L.P. Foresite Capital Opportunity Management V LLC Tananbaum James B. 10% Owner | 700,000 | $2.97 | $2,079,000 | 1,385,825 (Indirect) | View |
| 2022-12-29 Purchase | 2023-01-03 4:24 pm | Theseus Pharmaceuticals Inc. | THRX | Foresite Capital Management V LLC Foresite Capital Fund V L.P. Foresite Capital Opportunity Fund V L.P. Foresite Capital Opportunity Management V LLC Tananbaum James B. 10% Owner | 500,000 | $5 | $2,500,000 | 1,209,275 (Indirect) | View |
| 2022-12-29 Purchase | 2023-01-03 07:05 am | Theseus Pharmaceuticals Inc. | THRX | HAYDEN DONALD J JR Director | 10,000 | $4.9989 | $49,989 | 10,000 (Direct) | View |
| 2022-11-30 Purchase | 2022-12-01 4:35 pm | Theseus Pharmaceuticals Inc. | THRX | Dahms Bradford D. Chief Financial Officer | 1,502 | $6.657 | $10,000 | 6,142 (Direct) | View |
| 2022-11-11 Purchase | 2022-11-14 4:12 pm | Theseus Pharmaceuticals Inc. | THRX | CLACKSON TIMOTHY P President and CEO | 2,500 | $6.798 | $16,995 | 351,030 (Direct) | View |
| 2022-11-07 Purchase | 2022-11-09 4:29 pm | Theseus Pharmaceuticals Inc. | THRX | GORDON CARL L Director 10% Owner | 192,000 | $5.21 | $1,000,320 | 17,233,668 (Indirect) | View |
| 2022-11-07 Purchase | 2022-11-09 4:25 pm | Theseus Pharmaceuticals Inc. | THRX | ORBIMED ADVISORS LLC OrbiMed Capital GP VII LLC OrbiMed Genesis GP LLC Director 10% Owner | 192,000 | $5.21 | $1,000,320 | 17,233,668 (Indirect) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2024-02-14 Disposition | 2024-02-14 4:03 pm | N/A N/A | Theseus Pharmaceuticals Inc. | THRX | Yi Kathy Director | 102,884 | $0 | 0 (Direct) | View |
| 2024-02-14 Disposition | 2024-02-14 4:03 pm | N/A N/A | Theseus Pharmaceuticals Inc. | THRX | Stein Steven H Director | 3,250 | $0 | 0 (Direct) | View |
| 2024-02-14 Equity Swap | 2024-02-14 4:02 pm | N/A N/A | Theseus Pharmaceuticals Inc. | THRX | ORBIMED ADVISORS LLC OrbiMed Capital GP VII LLC OrbiMed Genesis GP LLC Director 10% Owner | 17,713,600 | $0 | 0 (Indirect) | View |
| 2024-02-14 Disposition | 2024-02-14 4:01 pm | N/A N/A | Theseus Pharmaceuticals Inc. | THRX | HAYDEN DONALD J JR Director | 3,250 | $0 | 0 (Direct) | View |
| 2024-02-14 Equity Swap | 2024-02-14 4:01 pm | N/A N/A | Theseus Pharmaceuticals Inc. | THRX | HAYDEN DONALD J JR Director | 10,000 | $0 | 0 (Direct) | View |
| 2024-02-14 Disposition | 2024-02-14 4:01 pm | N/A N/A | Theseus Pharmaceuticals Inc. | THRX | GORDON CARL L Director 10% Owner | 3,250 | $0 | 0 (Direct) | View |
| 2024-02-14 Equity Swap | 2024-02-14 4:01 pm | N/A N/A | Theseus Pharmaceuticals Inc. | THRX | GORDON CARL L Director 10% Owner | 17,713,600 | $0 | 0 (Indirect) | View |
| 2024-02-14 Disposition | 2024-02-14 4:00 pm | N/A N/A | Theseus Pharmaceuticals Inc. | THRX | Dukes Iain D. Director | 445,209 | $0 | 0 (Direct) | View |
| 2024-02-14 Equity Swap | 2024-02-14 4:00 pm | N/A N/A | Theseus Pharmaceuticals Inc. | THRX | Dukes Iain D. Director | 388,324 | $0 | 0 (Direct) | View |
| 2024-02-14 Disposition | 2024-02-14 4:00 pm | N/A N/A | Theseus Pharmaceuticals Inc. | THRX | Dahms Bradford D. President and CFO | 349,614 | $0 | 0 (Direct) | View |
| 2024-02-14 Equity Swap | 2024-02-14 4:00 pm | N/A N/A | Theseus Pharmaceuticals Inc. | THRX | Dahms Bradford D. President and CFO | 8,150 | $0 | 0 (Direct) | View |
| 2023-11-06 Exercise | 2023-11-07 4:03 pm | N/A 2030-12-23 | Theseus Pharmaceuticals Inc. | THRX | Shakespeare William See Remarks | 251,084 | $0 | 732,668 (Direct) | View |
| 2023-11-06 Exercise | 2023-11-07 4:03 pm | N/A N/A | Theseus Pharmaceuticals Inc. | THRX | Shakespeare William See Remarks | 251,084 | $0.32 | 732,668 (Direct) | View |
| 2023-06-13 Option Award | 2023-06-13 5:30 pm | N/A 2033-06-12 | Theseus Pharmaceuticals Inc. | THRX | Stein Steven H Director | 22,750 | $0 | 22,750 (Direct) | View |
| 2023-06-13 Option Award | 2023-06-13 5:30 pm | N/A 2033-06-12 | Theseus Pharmaceuticals Inc. | THRX | Yi Kathy Director | 22,750 | $0 | 22,750 (Direct) | View |
| 2023-06-13 Option Award | 2023-06-13 5:29 pm | N/A 2033-06-12 | Theseus Pharmaceuticals Inc. | THRX | HAYDEN DONALD J JR Director | 22,750 | $0 | 22,750 (Direct) | View |
| 2023-06-13 Option Award | 2023-06-13 5:29 pm | N/A 2033-06-12 | Theseus Pharmaceuticals Inc. | THRX | GORDON CARL L Director 10% Owner | 22,750 | $0 | 22,750 (Direct) | View |
| 2023-06-13 Option Award | 2023-06-13 5:28 pm | N/A 2033-06-12 | Theseus Pharmaceuticals Inc. | THRX | Dukes Iain D. Director | 22,750 | $0 | 22,750 (Direct) | View |
| 2023-03-01 Option Award | 2023-03-02 07:02 am | N/A N/A | Theseus Pharmaceuticals Inc. | THRX | Rivera Victor Chief Scientific Officer | 16,250 | $0 | 16,250 (Direct) | View |
| 2023-03-01 Option Award | 2023-03-02 07:01 am | N/A N/A | Theseus Pharmaceuticals Inc. | THRX | Shakespeare William See Remarks | 21,250 | $0 | 21,250 (Direct) | View |
| 2023-03-01 Option Award | 2023-03-02 07:01 am | N/A N/A | Theseus Pharmaceuticals Inc. | THRX | Kerstein David Chief Medical Officer | 17,500 | $0 | 17,500 (Direct) | View |
| 2023-03-01 Option Award | 2023-03-02 07:00 am | N/A N/A | Theseus Pharmaceuticals Inc. | THRX | Dahms Bradford D. Chief Financial Officer | 17,500 | $0 | 17,500 (Direct) | View |
| 2023-03-01 Option Award | 2023-03-02 07:00 am | N/A N/A | Theseus Pharmaceuticals Inc. | THRX | CLACKSON TIMOTHY P President and CEO | 45,625 | $0 | 45,625 (Direct) | View |
| 2023-02-17 Option Award | 2023-02-21 07:03 am | N/A 2033-02-17 | Theseus Pharmaceuticals Inc. | THRX | Shakespeare William See Remarks | 127,500 | $0 | 127,500 (Direct) | View |
| 2023-02-17 Option Award | 2023-02-21 07:03 am | N/A 2033-02-17 | Theseus Pharmaceuticals Inc. | THRX | Rivera Victor Chief Scientific Officer | 97,500 | $0 | 97,500 (Direct) | View |
| 2023-02-17 Option Award | 2023-02-21 07:03 am | N/A 2033-02-17 | Theseus Pharmaceuticals Inc. | THRX | Kerstein David Chief Medical Officer | 105,000 | $0 | 105,000 (Direct) | View |
| 2023-02-17 Option Award | 2023-02-21 07:01 am | N/A 2033-02-17 | Theseus Pharmaceuticals Inc. | THRX | Dahms Bradford D. Chief Financial Officer | 105,000 | $0 | 105,000 (Direct) | View |
| 2023-02-17 Option Award | 2023-02-21 07:00 am | N/A 2033-02-17 | Theseus Pharmaceuticals Inc. | THRX | CLACKSON TIMOTHY P President and CEO | 273,750 | $0 | 273,750 (Direct) | View |
| 2022-10-17 Option Award | 2022-10-19 07:18 am | N/A 2032-10-17 | Theseus Pharmaceuticals Inc. | THRX | Stein Steven H Director | 60,000 | $0 | 60,000 (Direct) | View |
| 2022-06-10 Option Award | 2022-06-13 8:13 pm | N/A 2032-06-09 | Theseus Pharmaceuticals Inc. | THRX | Yi Kathy Director | 30,000 | $0 | 30,000 (Direct) | View |
| 2022-06-10 Option Award | 2022-06-13 8:12 pm | N/A 2032-06-09 | Theseus Pharmaceuticals Inc. | THRX | Dukes Iain D. Chairman | 45,000 | $0 | 45,000 (Direct) | View |
| 2022-06-10 Option Award | 2022-06-13 8:10 pm | N/A 2032-06-09 | Theseus Pharmaceuticals Inc. | THRX | GORDON CARL L Director 10% Owner | 30,000 | $0 | 30,000 (Direct) | View |
Ownership | 2022-06-13 5:15 pm | N/A N/A | Theseus Pharmaceuticals Inc. | THRX | Foresite Capital Management V LLC Foresite Capital Fund V L.P. Foresite Capital Opportunity Fund V L.P. Foresite Capital Opportunity Management V LLC Tananbaum James B. 10% Owner | 0 | $0 | 4,294,621 (Indirect) | View |
| 2022-05-17 Option Award | 2022-05-18 4:27 pm | N/A 2032-05-17 | Theseus Pharmaceuticals Inc. | THRX | HAYDEN DONALD J JR Director | 60,000 | $0 | 60,000 (Direct) | View |